Medicine passport
Tecartus
The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.
- Active substance
- Brexucaptagenum autoleucelum (Jeder patientenspezifische Einzel-Infusionsbeutel enthält eine Dispersion von Anti-CD19-CAR-T-Zellen in ca. 68 mL für eine Zieldosis von 2x10e6 Anti-CD19-CAR-positiven + Lebensfähigen T-Zellen/kg Körpergewicht (Spanne: 1 + 0x10e6–2 + 0x10e6 Zellen/kg) + Mit maximal 2x10e8 Anti-CD19-CAR-positiven + Lebensfähigen T-Zellen)
- Strength
- Not stated by the register
- Form
- ATC code
- L01XL06
- Registered in
- Switzerland · Gilead Sciences Switzerland Sàrl
- Prescription
- Prescription only
- Zulassungsnummer
- 67884
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30
Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.
Listed in other countries
No other register Mediclarum reads lists a product with this active substance, strength and form.
Same active substance, but no match for this strength and form
- Spain: 1 products · Every strength and form
- Canada: 2 products · Every strength and form
- Netherlands: 1 products · Every strength and form